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Abstract
Background: The simultaneous production of various recombinant proteins in every cell of a
culture is often needed for the production of virus-like particles (VLP) or vectors for gene therapy.
A common approach for such a purpose is the coinfection of insect cell cultures with different
recombinant baculoviruses, each containing one or more recombinant genes. However, scarce
information exists regarding kinetics during multiple infections, and to our knowledge, no studies
are available on the behavior of the different populations that arise during coinfections. Such
information is useful for designing infection strategies that maximize VLP or vector yield. In this
work, kinetics of cell populations expressing rotavirus GFPVP2 (infected with bacGFPVP2), VP6
(infected with bacVP6), or both proteins simultaneously (coinfected with both baculoviruses) were
followed by flow cytometry.
Results: In single infections, the population infected with any of the recombinant baculoviruses
followed the Poisson distribution, as the population expressing a recombinant protein exhibited a
hyperbolic-type function with respect to the multiplicity of infection (MOI) up to 5 pfu/cell. In
coinfections, the population fraction expressing each recombinant protein could not be anticipated
from results of single infections, as in some cases interference and synergistic effects were found.
Only cultures with a total MOI below 5 pfu/cell followed the Poisson distribution. For cultures with
a MOI of bacGFPVP2 above that of bacVP6 (overall MOI above 5 pfu/cell), the total population
expressing one or both recombinant proteins was as low as 50% below that predicted by Poisson.
In contrast, the population fraction expressing VP6 increased in coinfections, compared to that in
single infections. The largest population fraction simultaneously expressing both recombinant
proteins was 58%, and corresponded to cultures infected at a MOI of 5 and 1 pfu/cell of bacGFPVP2
and bacVP6, respectively.
Conclusion: The infection conditions that maximize the cell population simultaneously expressing
two recombinant proteins were determined. Such conditions could not have been anticipated from
population kinetics in individual infections. This information should be taken into account for
improved simultaneous production of various recombinant proteins in any work dealing with
coinfections.
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Background
Virus-like particles (VLP) are structurally identical to
native viruses, but they lack the viral genetic material [1].
VLP are obtained when the major viral structural proteins
are simultaneously expressed in a recombinant system.
There exists an increasing interest on VLP production due
to their promising applications as vaccines, as delivery
vehicles for substances or genes, or as biosensors [1]. A
recent example of the importance of VLP is the recent
approval of Merck's vaccine against human papilloma
virus. The production of VLP is a complex process and a
challenging task, as it requires the simultaneous expres-
sion of various recombinant proteins. Due to its versatility
and simplicity for coexpressing various recombinant
genes, the insect-cell baculovirus expression vector system
(IC-BEVS) has been commonly employed for producing
VLP of several viruses.
The simultaneous production of several proteins in insect
cells requires the delivery of various genes, either by a
number of individual baculoviruses or by employing a
single virus that contains several genes [2-4]. Of these
strategies, the use of individual baculoviruses allows the
manipulation of the concentration of each protein by
changing the multiplicity of infection (MOI) of each virus
[3,5,6]. In this way, the stoichiometry between the struc-
tural proteins may be controlled. In some VLP, which can
have variable protein composition, changes in the ratio
between structural proteins result in different VLP compo-
sitions, which can yield particles with different immuno-
genicity [5,6]. It is also possible that different
stoichiometries between the structural proteins result in
changes in VLP assembly efficiencies or kinetics, although
this remains to be studied. Therefore, MOI manipulation
is a powerful tool for finding the conditions required for
maximizing the assembly of a desired VLP. However, little
is known about the performance of simultaneous infec-
tions with various recombinant baculoviruses, specifically
regarding cell population kinetics and possible interfer-
ences or synergies between the coinfecting viruses.
Rotavirus is a triple-layered virus that is responsible of gas-
troenteritis. The inner layer, a core-like particle, is consti-
tuted by VP2, surrounded by a second concentric layer
containing VP6. The third layer is formed by VP7 and
spikes of VP4 [7]. Recently, Mena et al. [8] studied the
accumulation in insect cells of double layered rotavirus-
like particles (dlRLP), that are constituted by the two inner
concentric layers. They found that the assembly of dlRLP
occurs intracellularly, and that, when expressed individu-
ally, both VP2 and VP6 form structures that cannot further
assemble into double-layered particles. Namely, under
such condition VP6 forms tubes whereas VP2 forms core-
like particles densely packed in ordered groups. Neither
tubes nor densely packed cores are accessible for interac-
tion with the other recombinant protein, and thus dlRLP
cannot be formed. These findings underline the impor-
tance of having both VP2 and VP6 available for assembly
into dlRLP in each cell of the culture and at the right time
to avoid the formation of structures composed only by a
single protein. A similar situation occurs when other VLP
are produced, such as adeno-associated viral vectors,
which require the simultaneous expression of the struc-
tural and non-structural proteins, as well as replication of
vector DNA in the same cell [9]. It can be anticipated that
appropriate infection strategies, based on the manipula-
tion of MOI, would maximize VLP yield. Several groups
have studied the dynamics of infection at various MOI,
while others have predicted by mathematical modeling
the percentage of the population infected under different
conditions [2-5,10-14]. Nonetheless, cell population
kinetics during the simultaneous infection with two
recombinant viruses have, to our knowledge, not been
studied
A powerful tool for assessing the dynamics of infection at
different MOI is flow cytometry. This methodology has
been used to determine the percentage of the population
infected at different MOI by a single type of virus [15,16],
for assessing the productivity of different cell lines [17], to
measure respiratory activity [18], to titer viruses [19], and
to determine transducing titers of gene delivery vectors
[20]. Flow cytometry has also been used to screen BF2 fish
cells simultaneously infected with non-recombinant
viruses of two different species; the pancreatic necrosis
virus and the hematopoietic necrosis virus [21]. In our
work, insect cells were infected with one or two different
recombinant baculoviruses, expressing rotavirus VP2 or
VP6, at different MOI. Utilizing flow cytometry we have,
for the first time, determined the kinetics of cell popula-
tions expressing either of the recombinant proteins during
simultaneous infections with both recombinant baculovi-
ruses and compared them with single infections. Moreo-
ver, we have determined the infection conditions required
to guarantee that the highest fraction of the population is
simultaneously expressing both recombinant proteins,
one of the necessary conditions for complete and efficient
dlRLP production.
Results
Cultures infected with a single baculovirus
Insect cell cultures individually infected with bacGFPVP2
or VP6 were analyzed by flow cytometry at 24 and 48
hours post-infection (hpi). MOI of 0.1, 1, 5, 10, and 20
pfu/cell were tested. Fluorescence histograms at 24 hpi are
shown in Figure 1, along with an uninfected control cul-
ture performed simultaneously. When analyzing these
results, it should be taken into account that fluorescence
emission was measured at two different wavelengths, 510
for GFPVP2 and 575 nm for immunolabeled gp64 andBMC Biotechnology 2007, 7:39 http://www.biomedcentral.com/1472-6750/7/39
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VP6. Thus, background fluorescence of uninfected cells
was different. Cells expressing a recombinant protein
could be easily distinguished from uninfected cells. The
distribution of the populations expressing GFPVP2 was
different from the one expressing VP6. Data extracted
from fluorescence histograms of duplicate cultures are
summarized in Figure 2A, where the fraction of the popu-
lation expressing a recombinant protein is reported rela-
tive to the total cell count (regardless of viability). It
should be considered that the analysis shown in Figure 1
allows the identification of the population expressing a
recombinant protein (either GFPVP2 or VP6), but not
necessarily that of infected cells, as expression of the
recombinant gene might be absent or inefficient even in
infected cells. A marker that has been used to monitor
infection by baculovirus is gp64 [22]. gp64 is the major
envelope glycoprotein of baculovirus [23], and accumu-
lates in the membrane of infected cells during the first 10
to 12 hpi [24]. To correlate infection with recombinant
protein expression, gp64 was immunodetected at 24 hpi
in cultures expressing GFPVP2 (Figures 1 and 2A). In addi-
tion, the population distribution predicted by Poisson:
commonly used to describe infection, is also plotted in
Figure 2A[3]. The population fraction expressing any of
the recombinant proteins or gp64 increased in a hyper-
bolic-type function with MOI up to 5 pfu/cell, and then
remained constant for MOI above 5 pfu/cell. Such a
behavior is in agreement with predictions based on the
Poisson distribution. Cultures infected with bacVP6 or
bacGFPVP2 had a similar trend, which was also similar to
the population expressing gp64 in the cultures infected
with bacGFPVP2. The similar behavior between cells
expressing GFPVP2, gp64 and VP6 confirms that the
results obtained from cells immunostained for VP6 were
representative of the population expressing that recom-
binant protein, and that both recombinant baculoviruses
were equally infective. Results obtained at 48 hpi are
shown in Figure 2B. The Poisson distribution is not plot-
ted in Figure 2B, as secondary infection had occurred at
this time, and different calculations are needed to predict
the infected population under these conditions (see dis-
cussion below). At 48hpi, between 65 to 90% of the cells
were expressing either recombinant protein, regardless of
the MOI. However, at MOI below 10 pfu/cell, a smaller
population of cells expressed GFPVP2, in comparison
with that expressing VP6.
Handling of cultures expressing GFPVP2 for FACS analysis
was easier than those for VP6, as VP6 had to be immunos-
tained by a laborious procedure, whereas intrinsic fluores-
cence of GFPVP2 facilitated the assay. Therefore the
population containing this recombinant protein was fol-
lowed every 24 h until 96 hpi. Results are shown in Figure
3A. The population expressing GFPVP2 reached a maxi-
mum at 24 hpi for cultures infected at a MOI of 5 pfu/cell
or higher. In contrast, such population reached a maxi-
mum until 48 hpi for cultures infected at MOI of less than
5 pfu/cell. In all cases, the percentage of the population
expressing a recombinant protein decreased after 48 hpi
(Figure 3B), probably due to degradation of the recom-
binant protein after loss of cell membrane integrity in
non-viable cells. Viability decreased steadily after infec-
tion, reaching 0% at 72 hpi in cultures infected at MOI of
10 and 20 pfu/cell. The rate of decrease of the viability was
lower as the MOI decreased.
Cultures simultaneously infected with bacGFPVP2 and 
bacVP6
Gating parameters used for discriminating between cells
expressing GFPVP2, VP6 or both proteins were set accord-
ing to fluorescence (emission) at 510 nm (corresponding
to GFP) and 575 nm (corresponding to R-phycoerythrin,
used to detect VP6) in uninfected cultures, cultures
expressing only GFPVP2, or cultures expressing VP6. Typ-
ical results are shown in Figures 4A–C. As expected, unin-
fected cultures had a low emission both at 510 or 575 nm
(Figure 4A), whereas cells infected with bacGFPVP2 had a
high emission at 510 nm (Figure 4B). Moreover, cells
infected with bacVP6 had a high fluorescence at 575 nm
(Figure 4C). Accordingly, gating parameters, which
allowed the differentiation between the three populations
present in coinfected cultures, could be set. Flow cytome-
try results of a culture simultaneously infected with
bacGFPVP2 and VP6 at 24 or 48 hpi are shown in Figure
4D and 4E, respectively. At 24 hpi many cells could be
clearly classified as expressing VP6, whereas only rela-
tively few cells were expressing both recombinant pro-
teins. At 48 hpi, only a few cells were not expressing a
recombinant protein, while most were either expressing
VP6 or both recombinant proteins simultaneously. A
small fraction of the population was expressing only
GFPVP2. A quantitative analysis of the flow cytometry
study is presented below.
The results obtained from 4 experimental setups per-
formed in duplicate are summarized in Figure 5. Cultures
were infected at different MOI combinations of
bacGFPVP2 and bacVP6. MOI of each virus were not
increased above 5 pfu/cell, as higher MOI did not result in
a higher population fraction expressing any of the recom-
binant proteins in single infections (Figure 2). In most
cases, the largest fraction of the population expressed VP6,
regardless of the MOI of bacGFPVP2. The only exceptions
were the cultures infected with 0.1 and 5 pfu/cell of
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Fluorescence histogram analysis of cells infected with bacGFPVP2 or bacVP6 at different multiplicities of infection at 24 hpi Figure 1
Fluorescence histogram analysis of cells infected with bacGFPVP2 or bacVP6 at different multiplicities of 
infection at 24 hpi. Fluorescence of GFPVP2, immunolabeled gp64 in cells expressing GFPVP2, and immunolabeled VP6 are 
shown in black. A control-uninfected culture is shown in gray and marked as (*). Dotted vertical line corresponds to the fluo-
rescence gating used.BMC Biotechnology 2007, 7:39 http://www.biomedcentral.com/1472-6750/7/39
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hpi. In these cultures, the population expressing either of
the recombinant proteins was about the same. It should
be noted that, in the extreme situation, the population
fraction expressing VP6 was 17.5 times larger than that
expressing GFPVP2 (MOI bacVP6 1 pfu/cell, MOI
bacGFPVP2 0.1 pfu/cell, 24 hpi). The highest percentage
of the population expressing any recombinant protein
(VP6 or GFPVP2 or both) at 24 hpi was obtained at MOI
of 1 pfu/cell for both bacGFPVP2 and bacVP6, i.e. a total
MOI of 2 pfu/cell. Such population fraction was 15%
higher than that expressing any recombinant protein at
the highest total MOI tested, which corresponded to 6
pfu/cell (5 pfu/cell of bacGFPVP2 and 1 pfu/cell of VP6).
The population fraction expressing both recombinant
proteins at 24 hpi closely followed the population
expressing GFPVP2.
Coinfections had various effects on the population
expressing GFPVP2. In general, the cell population
expressing GFPVP2 in coinfected cultures was smaller
than in single-infected cultures at the same MOI, except in
two cases at 24 hpi (Figures 2 and 5). Namely, in cultures
infected at a MOI of 0.1 pfu/cell of each baculovirus, the
population expressing GFPVP2 was duplicated, in com-
parison to that observed in single infections. Moreover, at
0.1 pfu/cell of bacVP6 and 1 pfu/cell of bacGFPVP2, the
population expressing GFPVP2 was the same than that
observed in single infections. In contrast, the population
expressing VP6 at 24 hpi increased in coinfections, com-
pared to individual infections. In cultures infected at MOI
of 0.1 pfu/cell of bacVP6, 11.5% of the population
expressed VP6 in single-infected cultures, whereas in coin-
fections up to 45% of the population expressed VP6 (Fig-
ures 2 and 5). Something similar occurred at a MOI of
bacVP6 of 1pfu/cell, as 65% of the population expressed
VP6 in single-infected cultures, while in coinfections such
percentage increased to 70 – 85% at 24 hpi.
Cultures infected only with bacGFPVP2 Figure 3
Cultures infected only with bacGFPVP2. A. Kinetics of 
the fraction of the population expressing GFPVP2 in cultures 
infected only with bacGFPVP2. Numbers in figure legend 
refer to the different MOI used. B. Viability of cultures 
infected with bacGFPVP2. Media and difference between 
duplicate cultures are shown. Some error bars are smaller 
than the symbols shown.
Cultures individually infected with bacGFPVP2 or bacVP6 Figure 2
Cultures individually infected with bacGFPVP2 or 
bacVP6. Both sets of cultures are plotted in the same 
graphs to allow comparison. A. Fraction of the population 
expressing GFPVP2, gp64, or VP6 at 24 hours post infection 
(hpi). The probability (p) of a population of being infected by 
w virus, predicted by Poisson, is shown as a solid line. B. The 
same cultures as in A but at 48 hpi. Media and difference 
between duplicate cultures are shown in Y axis error bars. X 
error bars represent the standard deviation of titers of the 
viral stocks, adjusted to each MOI. Some error bars are 
smaller than the symbols shown.BMC Biotechnology 2007, 7:39 http://www.biomedcentral.com/1472-6750/7/39
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Identification of cell populations simultaneously expressing GFPVP2 and VP6 Figure 4
Identification of cell populations simultaneously expressing GFPVP2 and VP6. Cultures shown in panels A to C 
were used for setting the gating limits for analysis of coinfected cultures. A. Uninfected control culture. B. Culture at 24 hpi 
infected with bacGFPVP2 at a MOI of 5 pfu/cell. C. Culture at 24 hpi infected with bacVP6 at a MOI of 5 pfu/cell. D. Culture 
coinfected with bacGFPVP2 and bacVP6 with a MOI of 0.1 pfu/cell of each virus, 24 hpi. E. Culture coinfected with bacGFPVP2 
and bacVP6 with a MOI of 0.1 pfu/cell of each virus, 48 hpi.BMC Biotechnology 2007, 7:39 http://www.biomedcentral.com/1472-6750/7/39
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Compared to 24 hpi, the population expressing any of the
recombinant protein increased at 48 hpi (Figure 5). This
increase occurred even in cultures infected with a MOI of
bacGFPVP2 of 5 pfu/cell; a behavior not observed in indi-
vidual infections. The population fraction expressing VP6
at 48 hpi reached 98% (considering the error bars) in cul-
tures infected at MOI of 0.1 or 1 pfu/cell of any of the bac-
uloviruses. In most cases the percentage of the population
expressing GFPVP2 at 48 hpi was smaller than that
expressing VP6, with the exception of the cultures infected
with 0.1 pfu/cell of bacVP6 and 5 pfu/cell of bacGFPVP2,
where the population expressing either protein was equal.
The condition that resulted in the highest percentage of
the population simultaneously expressing both recom-
binant proteins was a MOI of bacGFPVP2 of 5 pfu/cell
and 1 pfu/cell of bacVP6. Such condition resulted in 48%
and 58% of the population at 24 and 48 hpi, respectively,
simultaneously expressing both recombinant proteins.
Populations expressing the recombinant proteins were
not followed after 48 hpi as further infections by progeny
viruses were not expected after 48 hpi, and a rapid decline
in viability was observed after this time (data not shown).
To better appreciate the effect of coinfections, the popula-
tion expressing any of the recombinant proteins (GFPVP2,
VP6, or both) at 24 hpi is shown in Figure 6 as a function
of total MOI (MOI bacGFPVP2 + MOI bacVP6). For com-
parison, the Poisson distribution is also plotted. It can be
seen that coinfected cultures with a MOI of bacVP6 equal
or higher than that of bacGFPVP2 followed the Poisson
distribution. However, cultures where the MOI of
bacGFPVP2 was 5, 10, or 50 times higher than that of
bacVP6 had a much lower population expressing any of
the recombinant proteins than that predicted by the Pois-
son distribution at the corresponding cumulative MOI.
Discussion
Previous reports [15-17] and this work demonstrate the
utility of flow cytometry for monitoring recombinant pro-
tein expression. In this work, a wider screening of recom-
binant protein expression at different MOI and at
different times postinfection was performed, in addition
to following the populations expressing two recombinant
proteins during coinfections. At 24 hpi, the percentage of
the population expressing VP6 and gp64 closely followed
the Poisson distribution. This observation is relevant, as it
has been shown that various culture variables, including
medium composition, mode of culture, temperature, etc.,
can affect infection [25-27]. The percentage of the popula-
tion expressing a recombinant protein did not reach
100%, most probably due to the viability of cultures at the
time of infection, which was between 96 and 98%. It
should be noted that the population expressing GFPVP2
at 24 hpi with a MOI below 5 pfu/cell was in most cases
lower than that expressing gp64 (detected in the culture
infected with bacGFPVP2) or VP6. It is possible that the
smaller population expressing GFPVP2 was a result of the
slower production rate of this protein in comparison with
VP6, as has been observed previously [3,4,14]. Thus, in
some cells the amount of GFPVP2 at 24 hpi may be below
the detection limit of the flow cytometer. It should be
taken into account that, according to the life cycle of bac-
ulovirus, production of GFPVP2 would start around 20
hpi, as its gene is under the very late polh promoter [24].
In contrast, the population expressing gp64, which is
expressed in the early and late phases of infection (from 0
to 20–24 hpi), behaved as VP6, which is also under the
polh  promoter but has a higher production rate than
GFPVP2 [3]. Thus, the observed difference cannot be
attributed to a difference in infectivity between the two
recombinant viruses.
Measurements performed at 24 hpi reflect primary infec-
tion. At 48 hpi, the population of cells expressing a recom-
binant protein increased in cultures infected at MOI
below 5 pfu/cell. Such an increase was a result of infection
by the viral progeny produced during the late phase of the
primary infection (12–24 hpi, [24]). At 48 hpi, secondary
infection resulted in a similar population of cells express-
ing VP6 regardless of differences in the MOI (Figure 2). In
contrast, the population expressing GFPVP2 at MOI
below 10 pfu/cell did not catch up at 48 hpi with that at
the higher MOI of 10 or 20 pfu/cell. Such a lower percent-
age of population expressing GFPVP2 at 48 hpi may be a
result of the rapid decline in viability observed in these
cultures (Figure 3B), which did not occur in cultures
expressing VP6 (data not shown). Wu et al. [28] also
observed that infection with baculoviruses containing dif-
ferent recombinant genes results in different cell death
kinetics. The decrease in viability was faster as the MOI
increased, similarly to what Wu et al. [28] observed in the
range of 0.5 to 10 pfu/cell.
In general, population fractions obtained from individu-
ally infected cultures cannot be extrapolated to coinfec-
tions, a phenomenon that has not been previously
described in coinfections with two different recombinant
viruses of the same species. The increase of the population
expressing VP6 in coinfected cultures may be a result of a
cooperative action between both baculoviruses. Cultures
infected at low MOI of bacVP6 would result in only a frac-
tion of the population infected with this virus. Progeny
virus would begin to bud from 12 hpi [11] and infect cells
still susceptible to additional infection. It has been shown
that virus binding to infected cells can occur up to 24 hpi
[10]. Therefore, cells initially infected with bacGFPVP2
were still susceptible to additional infection by bacVP6,
but, in contrast to single infections at low MOI, all the
viral proteins and transcription factors of the very late
phase of infection would be already present when the VP6BMC Biotechnology 2007, 7:39 http://www.biomedcentral.com/1472-6750/7/39
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gene reached the cell nucleus. This may occur as early as 1
hour after progeny virus budding [10]. Accordingly, tran-
scription of the VP6 gene could start, during secondary
infection, as early as 13 h after the initial infection by
bacGFPVP2. This would explain the higher population
expressing VP6 in coinfections in comparison to individ-
ual infections. According to this hypothesis, the difference
between the populations expressing VP6 in coinfections
or in single infections roughly corresponded to the frac-
tion of cells simultaneously expressing both recombinant
proteins. A different situation was observed in the case of
the population expressing GFPVP2. At MOI of 5 pfu/cell,
the population expressing GFPVP2 decreased around 30%
in coinfections compared to single infections. In general,
coinfections at high MOI of GFPVP2 resulted in a lower
population expressing a recombinant protein. It appears
that secondary infection of bacVP6 interferes with the
expression of GFPVP2 by a mechanism still unknown. A
similar phenomenon was observed by Alonso et al. [21],
in, to our knowledge, the only other work characterizing
Population expressing GFPVP2, VP6, both recombinant proteins, or any recombinant protein (either GFPVP2 or VP6, or both) Figure 5
Population expressing GFPVP2, VP6, both recombinant proteins, or any recombinant protein (either GFPVP2 or VP6, or both). 
Media and difference between duplicate cultures are shown. Some error bars are smaller than the symbols shown.BMC Biotechnology 2007, 7:39 http://www.biomedcentral.com/1472-6750/7/39
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coinfections with flow cytometry, although using non-
recombinant viruses. In such work, coinfections with
hematopoietic necrosis virus and hepatic necrosis virus
were screened in a fish cell line. The hepatic necrosis virus
interfered with growth of the hematopoietic necrosis
virus. However, care should be taken when comparing our
work with that of Alonso et al. [21], as they worked with
two different virus species. Following mRNA kinetics may
help elucidate the interference mechanism of bacVP6 with
the expression of GFPVP2. Vieira et al. [4] followed the
kinetics of baculovirus replication and found that the
number of copies of baculovirus DNA coding for VP2 was
about half of that coding for VP6 in coinfected cultures,
which could explain a less efficient secondary infection by
bacGFPVP2. They also found that no difference exists
between the mRNA stability of VP2 or VP6 expressed in
the insect-cell baculovirus system. It remains to be deter-
mined if the same situation occurs in the case of the fusion
gene GFPVP2.
We have previously compared the production of VP2 and
VP6 upon infection or coinfection of SF9 cells [3]. We
found that the production rates of VP2 and VP6 were sim-
ilar in individual infections or coinfections at an MOI of
5 pfu/cell. In this work, we did not follow the recom-
binant protein production rates. However, we did observe
that in the culture coinfected with 5 pfu/cell of
bacGFPVP2 and 1 pfu/cell of bacVP6 (the closest condi-
tions to our previous study), the population fraction
expressing each of the recombinant proteins was similar
to that observed in individually infected cultures. It can be
inferred that such cultures would also have a similar
recombinant protein production rate, as the cultures we
have coinfected in the past at a MOI of 5 pfu.cell.
For efficient production of rotavirus like-particles, ade-
quate VLP assembly would require the simultaneous
expression of both GFPVP2 and VP6 by the largest popu-
lation of cells [8]. Such situation was encountered at a
MOI of 5 pfu/cell of bacGFPVP2 and 1 pfu/cell of bacVP6,
with 58% of the population expressing both recombinant
proteins at 48 hpi. It was observed that the population
simultaneously expressing both recombinant proteins
closely followed the population expressing GFPVP2, indi-
cating that expression of bacGFPVP2 was the limiting
step. We are now working on kinetic studies of the pro-
duction of single- or double shelled rotavirus-like parti-
cles upon infection with bacGFPVP2 and bacVP6.
The characteristics of a recombinant protein and expres-
sion system directly affect the production kinetics and
determine the limiting steps during its biosynthesis. For
instance, molecular weight, posttranslational modifica-
tions, the site of accumulation, and other characteristics
can affect protein yields. Accordingly, the results pre-
sented here can serve as a general practical guideline but
inherent characteristics of each particular case must be
considered.
Conclusion
In this work we have, for the first time determined the
effect of the simultaneous infection with two recom-
binant baculovirus on the populations expressing two
recombinant proteins. The kinetics of cell populations
expressing both recombinant proteins in coinfections
could not have been predicted from single infection data
or from the Poisson distribution based on theoretical con-
siderations. It was observed that secondary infection of
bacVP6 interfered with bacGFP2 expression, and also
resulted in a higher percentage of the population express-
ing VP6. The MOI for each virus that resulted in the high-
est population percentage expressing both recombinant
proteins was found. The information generated in this
work describes a novel phenomenon and is useful for
designing rational infection strategies needed in several
applications for improving the simultaneous expression
of two recombinant proteins in systems based on viral
gene delivery. Future work in coinfections with several
recombinant baculoviruses for producing various pro-
teins by insect cells should take into account that the pop-
ulation behavior of individual infections may be different
to that in single infections.
Comparison of coinfected cultures at 24 hpi with the Poisson  distribution Figure 6
Comparison of coinfected cultures at 24 hpi with the 
Poisson distribution. The population fraction expressing 
any of the recombinant proteins (either GFPVP2 or VP6, or 
both) is shown. Numbers at the right of symbols are the MOI 
ratio between bacGFPVP2 and bacVP6.BMC Biotechnology 2007, 7:39 http://www.biomedcentral.com/1472-6750/7/39
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Methods
Cell culture and recombinant protein expression
High Five cells (Invitrogen, Carlsbad, CA, USA) were cul-
tivated in suspension in SF900-II medium (Invitrogen,
Carlsbad, CA, USA) in 250 mL shaker flasks with 60 mL of
working volume at 27°C and 115 rpm. Cell concentration
and viability prior to infection were determined with a
Coulter Counter (Coulter Instruments) and Trypan blue
exclusion in a hemacytometer, respectively. Two recom-
binant baculoviruses derived from Autographa californica
nucleopolyhedrovirus (AcMNPV) were used. One baculo-
virus contained the gene for the fusion protein GFPVP2
(bacGFPVP2, kindly provided by Prof. J. Cohen, INRA,
France [29]), and the other contained the gene of VP6
(bacVP6, strain SA11, kindly provided by Dr. S. López,
IBT-UNAM, Mexico). Both recombinant genes were under
the polh promoter. Viral stocks were titrated as described
in Mena et al. [30]. This method has typical standard devi-
ations between 10 and 30%. Cultures were infected at a
cell concentration of 0.5 × 106 cell mL-1 using the different
MOI described in the Result section.
Cell preparation for flow cytometry analysis
To obtain the required cell number for flow cytometry
analysis, 15 mL of culture infected with either bacVP6,
bacGFPVP2 or co-infected were centrifuged at 1,000× g for
10 min in an Eppendorf 5810R centrifuge (Hamburg,
Germany) at 4 °C degrees. The supernatant was discarded
and the pellet was washed with 15 mL of PBS and centri-
fuged at 1,000× g for 10 min. The pellet was then fixed
with 15 mL of 2% formaldehyde (Sigma-Aldrich, St,
Louis, MO, USA) in PBS for 15 min, and washed twice
with PBS. Cells were permeabilized for 15 min with 0.2%
sodium deoxycholate (Sigma-Aldrich, St. Louis, MO,
USA) in PBS with 2% bovine serum albumin (Sigma-
Aldrich, St, Louis, MO, USA), and washed twice with PBS.
For immunodetection of gp64 and VP6, one mL of pellet
was resuspended in 1 mL of PBS (0.2% BSA) with primary
antibody in dilution of 1:200 for 1 hr. The primary anti-
bodies used were a monoclonal antibody to VP6 (Clone
3C10, Biodesign, Saco, MA, USA), and a monoclonal anti-
body Fastplax™ to gp64 (Novagen, Darmstadt, Germany).
The cells were washed twice and resuspended in 1 mL of
PBS (0.2% BSA) with the secondary antibody at a dilution
of 1:200 for 1 h. The secondary antibody was a goat anti-
mouse coupled to R-phycoerythrin (Molecular Probes-
Invitrogen, Carlsbad, CA, USA). The cells were washed
twice with PBS and resuspended in 500 μL of PBS.
Flow cytometry analysis
A FACSort with CellQuest software (Becton-Dickinson,
Franklin Lakes, NJ, USA) was used. The FACSsort has one
light source (488 nm) with three-color fluorescence anal-
ysis. 100 μL of cell preparation was diluted with 400 μL of
PBS and analyzed in the FACS. Cells expressing GFPVP2
were identified by GFP fluorescence (λ excitation: 488
nm, λ emission: 510, FL1 channel). Cells expressing gp64
or VP6 were analyzed by R-phycoerythrin fluorescence (λ
excitation: 488 nm, λ emission: 575, FL2 channel). In all
cases, 10,000 events were analyzed.
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